Azithromycin Friedrich Eberth

Powder for concentrate for solution for infusion

Azithromycin Friedrich Eberth


dosage form

pack size


pharmaceutical registration number


500 mg

powder for concentrate for solution for infusion

1 vial



Active substance:

Pharmacotherapeutic group:  
Antibacterials for systemic use, macrolides.
ATC code: J01FA10

Mechanism of action:
The mechanism of action of azithromycin is based upon the suppression of protein synthesis by means of binding to the bacterial ribosomal 50S sub-unit, usually resulting in a bacteriostatic effect.

Therapeutic indications:
Azithromycin Friedrich Eberth is indicated in adults requiring initial intravenous therapy for the treatment of the following infections caused by azithromycin-susceptible pathogens:

  • community-acquired pneumonia, including Legionnaires’ disease
  • Pelvic inflammatory disease (PID)

In cases of severe pneumonia/pneumonia requiring intensive care and/or prevailing risk factors, combination therapy (e.g. with a beta-lactam antibiotic) is required. Azithromycin monotherapy is not indicated for complicated infections, particularly infections in which azithromycin-resistant pathogens cannot be ruled out.